Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib may effectively treat folliculitis decalvans.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

NFAT5 triggers atherosclerosis under stress by activating inflammation in blood vessels.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.